This is a preview of subscription content, log in via an institution to check access.
Reference
Tran AQ, et al. Cost effectiveness of neoadjuvant chemotherapy followed by interval cytoreductive surgery versus primary cytoreductive surgery for patients with advanced stage ovarian cancer during the initial treatment phase. Gynecologic Oncology : 19 Dec 2017. Available from: URL: http://doi.org/10.1016/j.ygyno.2017.12.015
Rights and permissions
About this article
Cite this article
Evaluating treatment options in AEOC: NACT vs primary surgery. PharmacoEcon Outcomes News 795, 15 (2018). https://doi.org/10.1007/s40274-018-4653-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-4653-4